ISSN 1671-5411 CN 11-5329/R
Volume 18 Issue 2
Mar.  2021
Turn off MathJax
Article Contents
Please cite this article as: TONG W, WANG JM, LI JY, LI PY, CHEN YD, ZHANG ZB, DONG W. Incidence, predictors, and prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pumping in the intensive care unit: a propensity score analysis. J Geriatr Cardiol 2021; 18(2): 123−134. DOI: 10.11909/j.issn.1671-5411.2021.02.003
Citation: Please cite this article as: TONG W, WANG JM, LI JY, LI PY, CHEN YD, ZHANG ZB, DONG W. Incidence, predictors, and prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pumping in the intensive care unit: a propensity score analysis. J Geriatr Cardiol 2021; 18(2): 123−134. DOI: 10.11909/j.issn.1671-5411.2021.02.003

Incidence, predictors, and prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pumping in the intensive care unit: a propensity score analysis

doi: 10.11909/j.issn.1671-5411.2021.02.003
*The authors contributed equally to this manuscript
More Information
  •  OBJECTIVE To explore the incidence, predictors, and prognosis of intra-aortic balloon pumping (IABP)-related thrombocytopenia in critically ill patients. METHODS This multi-center study used the eICU Collaborative Research Database V1.2, comprising data on > 130,000 patients from multiple intensive care units (ICUs) in America between 2014 and 2015. A total of 710 patients undergoing IABP were included. Thrombocytopenia was defined as a drop in platelet count > 50% from baseline. From the cohort, 167 patients who developed thrombocytopenia were matched 1:1 with 167 patients who did not, after propensity score (PS) matching. The associations between IABP-related thrombocytopenia and clinical outcomes were examined by multivariable logistic regression. RESULTS Among 710 patients undergoing IABP, 249 patients (35.07%) developed thrombocytopenia. The APACHE IVa score was a predictor of thrombocytopenia [adjusted odds ratio (OR) = 1.09, 95% confidence interval (CI): 1.02−1.15]. After 1:1 PS matching, in-hospital mortality (adjusted OR = 0.76, 95% CI: 0.37−1.56) and in-ICU mortality (adjusted OR = 0.74, 95% CI: 0.34−1.63) were similar between the thrombocytopenia and non-thrombocytopenia groups. However, major bleeding occurred more frequently in the thrombocytopenia group (adjusted OR = 2.54, 95% CI: 1.54−4.17). In-hospital length of stay (LOS) and in-ICU LOS were significantly longer in patients who developed thrombocytopenia than in those who did not (9.71 vs. 7.36, P < 0.001; 5.13 vs. 2.83, P < 0.001). CONCLUSIONS Among patients undergoing IABP in the ICUs, thrombocytopenia was not associated with a difference in in-hospital mortality or in-ICU mortality; however, thrombocytopenia was significantly associated with a greater risk of major bleeding and increased in-ICU and in-hospital LOS.
  • loading
  • [1]
    Stretch R, Sauer CM, Yuh DD, et al. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 2014; 64: 1407−1415. doi: 10.1016/j.jacc.2014.07.958
    Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol 2006; 97: 1391−1398. doi: 10.1016/j.amjcard.2005.11.070
    van Nunen LX, Noc M, Kapur NK, et al. Usefulness of intra-aortic balloon pump counterpulsation. Am J Cardiol 2016; 117: 469−476. doi: 10.1016/j.amjcard.2015.10.063
    Ferguson JJ 3rd, Cohen M, Freedman RJ Jr, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 2001; 38: 1456−1462. doi: 10.1016/S0735-1097(01)01553-4
    Parissis H, Graham V, Lampridis S, et al. IABP: history-evolution-pathophysiology-indications: what we need to know. J Cardiothorac Surg 2016; 11: 122. doi: 10.1186/s13019-016-0513-0
    Kapelios CJ, Terrovitis JV, Nanas JN. Current and future applications of the intra-aortic balloon pump. Curr Opin Cardiol 2014; 29: 258−265. doi: 10.1097/HCO.0000000000000059
    Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg 2011; 6: 147. doi: 10.1186/1749-8090-6-147
    Cohen M, Urban P, Christenson JT, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J 2003; 24: 1763−1770. doi: 10.1016/j.ehj.2003.07.002
    Roy SK, Howard EW, Panza JA, et al. Clinical implications of thrombocytopenia among patients undergoing intra-aortic balloon pump counterpulsation in the coronary care unit. Clin Cardiol 2010; 33: 30−35. doi: 10.1002/clc.20694
    Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med 1998; 105: 27−32. doi: 10.1016/S0002-9343(98)00128-4
    McCabe JC, Abel RM, Subramanian VA, et al. Complications of intra-aortic balloon insertion and counterpulsation. Circulation 1978; 57: 769−773. doi: 10.1161/01.CIR.57.4.769
    Sheng Z, Zhao H, Yan H, et al. Intra-aortic balloon pumping and thrombocytopenia in patients with acute coronary syndrome: incidence, risk factors, and prognosis. Herz 2018; 43: 555−564. doi: 10.1007/s00059-017-4599-5
    Essay P, Shahin TB, Balkan B, et al. The connected intensive care unit patient: exploratory analyses and cohort discovery from a critical care telemedicine database. JMIR Med Inform 2019; 7: e13006. doi: 10.2196/13006
    McShea M, Holl R, Badawi O, et al. The eICU research institute: a collaboration between industry, health-care providers, and academia. IEEE Eng Med Biol Mag 2010; 29: 18−25. doi: 10.1109/MEMB.2009.935720
    Pollard TJ, Johnson AEW, Raffa JD, et al. The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Sci Data 2018; 5: 180178. doi: 10.1038/sdata.2018.178
    Vincent JL, Moreno R. Clinical review: scoring systems in the critically ill. Crit Care 2010; 14: 207. doi: 10.1186/cc8204
    Vora AN, Chenier M, Schulte PJ, et al. Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. Am Heart J 2014; 168: 189−196.e1. doi: 10.1016/j.ahj.2014.04.010
    De Labriolle A, Bonello L, Lemesle G, et al. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. Eur Heart J 2010; 31: 1079−1087. doi: 10.1093/eurheartj/ehp594
    Wang TY, Ou FS, Roe MT, et al. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation 2009; 119: 2454−2462. doi: 10.1161/CIRCULATIONAHA.108.827162
    Caixeta A, Dangas GD, Mehran R, et al. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Am Heart J 2011; 161: 298−306.e1. doi: 10.1016/j.ahj.2010.10.035
    Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. J Interv Cardiol 2008; 21: 350−356. doi: 10.1111/j.1540-8183.2008.00363.x
    Sekhon SS, Roy V. Thrombocytopenia in adults: a practical approach to evaluation and management. South Med J 2006; 99: 491−498. doi: 10.1097/01.smj.0000209275.75045.d4
    Hui P, Cook DJ, Lim W, et al. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 2011; 139: 271−278. doi: 10.1378/chest.10-2243
    Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation 2005; 111: 2671−2683. doi: 10.1161/CIRCULATIONAHA.104.518563
    EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689−1696. doi: 10.1056/NEJM199706123362401
    Crowther MA, Cook DJ, Meade MO, et al. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 2005; 20: 348−353. doi: 10.1016/j.jcrc.2005.09.008
    Ben Hamida C, Lauzet JY, Rézaiguia-Delclaux S, et al. Effect of severe thrombocytopenia on patient outcome after liver transplantation. Intensive Care Med 2003; 29: 756−762. doi: 10.1007/s00134-003-1727-x
    Fountain EM, Arepally GM. Etiology and complications of thrombocytopenia in hospitalized medical patients. J Thromb Thrombolysis 2017; 43: 429−436. doi: 10.1007/s11239-016-1467-8
  • 加载中


    通讯作者: 陈斌,
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(4)

    Article Metrics

    Article views (788) PDF downloads(47) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint